Jacob Robson M.D., M.S.

Assistant Professor of Pediatrics

Dr. Jacob Robson received his BA from Rice University and his MD (with honors) from the University of California San Francisco. He completed his pediatric residency and a chief residency at the Boston Combined Residency Program (Boston Children's Hospital and Boston Medical Center) and his pediatric gastroenterology fellowship at the University of California San Francisco. Dr. Robson was recognized with prestigious teaching awards in both residency and fellowship. During his pediatric gastroenterology fellowship, using funding from the Cystic Fibrosis Foundation, Dr. Robson received a MS in clinical research, focused on advanced biostatistics and epidemiology. While pursuing this training, Dr. Robson was the senior author on work showing that goals for growth in infants and toddlers with CF must be reconsidered now that early measurements have shifted to using WHO measurement scales. This work, which used CFF patient registry data, was initially presented at NACFC 2016 (Orlando) and was subsequently published in the Journal of Cystic Fibrosis. Dr. Robson is currently an Assistant Professor of Pediatrics at the University of Utah, working in the Division of Pediatric Gastroenterology. Dr. Robson is board certified in general pediatrics and pediatric gastroenterology and sees pediatric patients at Primary Children's Hospital and the University of Utah. Dr. Robson is currently funded by the CFF DIGEST Award, which allows for regular participation in CF clinic and protected time for clinical research. Dr. Robson continues to study the link between early growth and long-term CF clinical outcomes, including lung function, BMI and transplant-free survival. He is working locally and with the FIRST study, based at the University of Wisconsin, to assess the clinical impact of early gastrostomy tube placement in children with CF, focusing on those who are showing poor growth prior to age two.